1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Respiratory Therapy News MARCH 2015

Respiratory Therapy News MARCH 2015

  • March 2015
  • -
  • Espicom Business Intelligence
  • -
  • 15 pages

Industry Trend Analysis - Anti-PD1 Race Continues Despite BMS' NSCLC Approval Win
Industry Trend Analysis - Ruthigen Reverse Merger To Boost Pulmatrix' Respiratory Product Development
Industry Brief - AstraZeneca Completes Purchase Of Actavis' Branded Respiratory Assets
Industry Brief - Sunovion Initiates SUN-101/eFlow Phase III Trial Programme In COPD
Industry Brief - Merrimack Initiates Biomarker-Selected MM-121 Phase II Trial
Industry Brief - AeroVanc Phase II Trial Meets Primary Endpoint Of MRSA Reduction In CF
Industry Brief - AirFluSal Forspiro Launched In Portugal/Ireland
Industry Brief - Positive Results From AstraZeneca's PT003 COPD Programme
Industry Brief - Combination Cell-Gene Therapy For LC To Be Tested In UK Patients
Industry Brief - Biota Commences Dosing In Vapendavir Phase IIb Trial For Asthma
Industry Brief - Coronado/NeuPharma To Co-Develop Covalent Third-Generation EGFr Inhibitors
Industry Brief - Dako/Ono To Co-Develop PD-1 Companion Diagnostic For Opdivo
Industry Brief - FDA Accepts Rapamune sNDA For Priority Review In LAM
Industry Brief - OSE Pharma Launches IPO On Euronext Paris
Industry Brief - Bayer's Adempas Approved In Japan For PAH
Industry Brief - Eisai's Lenvatinib Extends OS In Phase II NSCLC Trial
Industry Brief - Abraxane Gains EU Approval For First-Line NSCLC
Industry Trend Analysis - Opdivo Set To Become First PD-1 Inhibitor On NSCLC Market Ahead Of Keytruda
Industry Brief - Actelion's NDA For Uptravi Accepted By FDA With Standard Review Time
Industry Brief - Kalydeco Gains FDA Approval For Expanded Age Range
Industry Brief - Zykadia Gains CHMP Positive Opinion For ALK+ NSCLC Previously Treated With Crizotinib
Industry Brief - N30 Pharmaceuticals Changes Name To Nivalis Therapeutics
Industry Brief - Takeda Acquires Select Portfolio From Neutec
Industry Brief - ACD's RNAscope Technology Supports Merrimack's MM-121 Phase II Trial
Industry Brief - Jubilant Gains New US Product Approvals
Industry Brief - Aeolus' AEOL 10150 Gains FDA ODD For IPF
Industry Trend Analysis - J&J Will Still Reap Potential Rewards From Galapagos' IPF Candidate
Industry Brief - FDA Grants ODD To Selten's Tacrolimus For PAH

Table Of Contents

Respiratory Therapy News MARCH 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.